首页> 外国专利> Method for treating a cancer patient based on atomic therapeutic indexes and non-radiation therapy

Method for treating a cancer patient based on atomic therapeutic indexes and non-radiation therapy

机译:基于原子治疗指数和非放射治疗的癌症患者治疗方法

摘要

The present invention relates to the generation of an Atomic Therapeutic Indicator (ATI) for a test sample by the quantification of manganese; in voxels of a 3D region of the sample, wherein the 3D region is topographically defined by co-ordinates X′×Y′×Z. The ATI is used to assess the radio-responsiveness i.e. sensitivity or resistance to radiation treatment, of a cancer i.e. a tumor/neoplasm. In a preferred embodiment, the present invention relates to a method of generating the ATI, assessing the radio-responsiveness of a tumor/neoplasm based on the ATI and, based on the assessment, either treating or not treating the tumor with radiation.;The present invention also relates to a method of determining if a cancer is likely to reoccur post radiation treatment comprising quantifying the level of manganese in voxels of a 3D region of a test sample from the cancer and determining the frequency of high metallomic regions (HMRs) in the cancer, wherein a high frequency of HMRs is indicative that the cancer is likely to reoccur and a low frequency of HMRs is indicative that the cancer is unlikely to reoccur; and associated methods of treatment.;The invention further relates to a method of determining the radio-responsiveness of a melanoma, the method comprising determining the level of melanin in a test sample from the melanoma, wherein the lower the level of melanin the more sensitive the melanoma is to radiation and the higher the level of melanin the more resistant the melanoma is to radiation; and associated methods of treatment.
机译:本发明涉及通过锰的定量产生用于测试样品的原子治疗指示剂(ATI)。在样本的3D区域的体素中,其中3D区域在地形上由坐标X'×Y'×Z定义。 ATI用于评估癌症即肿瘤/肿瘤的放射响应性,即敏感性或对放射治疗的抗性。在一个优选的实施方案中,本发明涉及一种产生ATI的方法,该方法基于ATI来评估肿瘤/肿瘤的放射反应性,并且基于该评估,是用放射线治疗还是不使用放射线治疗肿瘤。本发明还涉及一种确定癌症是否可能在放射治疗后再次发生的方法,该方法包括对来自癌症的测试样品的3D区域的体素中的锰水平进行定量,并确定高金属区域(HMR)的频率。所述癌症,其中高频率的HMR表明该癌症很可能再次发生,而低频率的HMR表明该癌症不太可能再次发生;本发明还涉及确定黑色素瘤的放射反应性的方法,该方法包括确定来自黑色素瘤的测试样品中黑色素的水平,其中黑色素的水平越低越敏感。黑色素瘤对放射线的影响,黑色素水平越高,黑色素瘤对放射线的抵抗力越高;以及相关的治疗方法。

著录项

  • 公开/公告号US10302661B2

    专利类型

  • 公开/公告日2019-05-28

    原文格式PDF

  • 申请/专利权人 ATOMIC ONCOLOGY PTY LTD;

    申请/专利号US201715717246

  • 发明设计人 GEORGE L. GABOR MIKLOS;

    申请日2017-09-27

  • 分类号G01N21/31;G01N21/71;G01N22;G01N33/84;H01J49/16;G01N23/085;G01N23/223;G01N33/574;G01N33/48;

  • 国家 US

  • 入库时间 2022-08-21 12:13:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号